Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
The role of inflammation in cancer is controversial as both tumor-promoting and tumor-suppressive aspects of inflammation have been reported. In particular, it has been shown that pro-inflammatory cytokines, like interleukin-1α (IL-1α), IL-1β, IL-6, and tumor necrosis factor α (TNFα), may either pro...
Main Authors: | Haabeth, Ole Audun Werner, Lorvik, Kristina Berg, Yagita, Hideo, Bogen, Bjarne, Corthay, Alexandre |
---|---|
Format: | Online |
Language: | English |
Published: |
Taylor & Francis
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760324/ |
Similar Items
-
Molecular profiling of tumor-specific TH1 cells activated in vivo
by: Lorvik, Kristina Berg, et al.
Published: (2013) -
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
by: Haabeth, Ole Audun Werner, et al.
Published: (2011) -
A model for cancer-suppressive inflammation
by: Haabeth, Ole Audun Werner, et al.
Published: (2012) -
How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
by: Haabeth, Ole Audun Werner, et al.
Published: (2014) -
Coupling of HIV-1 Antigen to the Selective Autophagy Receptor SQSTM1/p62 Promotes T-Cell-Mediated Immunity
by: Andersen, Aram Nikolai, et al.
Published: (2016)